MAPT and Alzheimer disease: We and others used plasma neuronal-derived exosomes and revealed that amyloid β (Aβ)42, total tau (T-tau), and phosphorylated tau (P-tau)181 as well as other contents could differentiate AD patients from healthy individuals [6–9].